These MaR1 effects on colitis development were thought to be mediated by the activation of nuclear factor erythroid 2-related factor 2 (Nrf2) signalling, the inhibition of nuclear factor (NF)-κB signalling pathway, and the enhancement of the differentiation of M2 anti-inflammatory macrophages [61,62]. This evidence concerns the gene NFE2L2 and colitis.